These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Prognostic correlation of plasma cell acid phosphatase and beta-glucuronidase in multiple myeloma: a Southwest Oncology Group study. Saeed SM; Stock-Novack D; Pohlod R; Crowley J; Salmon SE Blood; 1991 Dec; 78(12):3281-7. PubMed ID: 1742488 [TBL] [Abstract][Full Text] [Related]
9. Discrepancies between the percentage of plasma cells in bone marrow aspiration and BM biopsy: Impact on the revised IMWG diagnostic criteria of multiple myeloma. Lee N; Moon SY; Lee JH; Park HK; Kong SY; Bang SM; Lee JH; Yoon SS; Lee DS Blood Cancer J; 2017 Feb; 7(2):e530. PubMed ID: 28211888 [No Abstract] [Full Text] [Related]
10. Acute myeloma. Ameér L Acta Med Scand; 1976; 199(6):543-4. PubMed ID: 937083 [TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of the ratio of bone marrow plasma cells in multiple myeloma]. Pasqualetti P; Colantonio D; Casale R Minerva Med; 1990 Mar; 81(3):129-33. PubMed ID: 2320280 [TBL] [Abstract][Full Text] [Related]
12. Initial bone marrow findings in multiple myeloma. Significance of plasma cell nodules. Buss DH; Prichard RW; Hartz JW; Cooper MR; Feigin GA Arch Pathol Lab Med; 1986 Jan; 110(1):30-3. PubMed ID: 3753566 [TBL] [Abstract][Full Text] [Related]
13. Hepatic and renal plasma cell lesions in a patient with multiple myeloma in hematological remission. Galani Z; Viniou N; Kyrtsonis MC; Sachanas S; Antoniou T; Dimopoulou MN; Vassilakopoulos TP; Korkolopoulou P; Nakopoulou L; Patsouris E; Pangalis GA Anticancer Res; 2007; 27(1B):571-4. PubMed ID: 17348443 [TBL] [Abstract][Full Text] [Related]